16 July 2026
MOH warns rising API costs could push up medicine prices and private treatment costs, while squeezing local generic drugmakers and distributors. The government’s drug may also come under pressure.
Tag: medicine price controls
9 December 2024
GP clinics are declining into a "sunset industry", says FPMPAM, "strangled" by mounting regulatory burdens like drug price displays, while doctor fees stagnate and TPAs grow. "There are too many regulations. They are killing the practice of medicine."
13 November 2024
MMA has expressed concern that the new medicine price transparency policy could have "serious, unintended consequences" for private GP clinics. MMA says requiring the display of all drug prices is impractical and will significantly raise operational costs.
27 July 2022
Pharmaceutical companies will be forced to disclose their drug development costs, including for cancer therapies, under the drug price transparency mechanism, says Khairy Jamaluddin.
7 February 2022
Pharma MNCs may deprioritise Malaysia into a “Wave 3” country, like Vietnam and South Africa, without access to innovative medicines if drug price controls are implemented.
2 February 2022
A cost-benefit analysis estimates T20 patients with private insurance may save RM1.6 billion yearly, four times higher than RM368 million for M40 and 22 times higher than RM73 million for B40.
31 January 2022
A cost-benefit analysis finds drug price controls may shutter 2,600 clinics and cause pay cuts, salary freezes, or layoffs of 91,000 to 136,000 private health care jobs.
23 October 2020
MOH only regulates medical professional fees (consultation and procedural fees) in private health facilities, not hospital fees.
17 July 2020
MOH and KPDNHEP are preparing a price control mechanism for medicines, says Dr Adham Baba.
6 March 2020
PhRMA says medicine price ceilings may delay patient access to new treatments.